Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  CGC | T.WEED.DB

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by Bobthebuilddron Jan 08, 2017 1:20pm
99 Views
Post# 25680597

RE:RE:Sales Numbers: I welcome critique of my math and numbers

RE:RE:Sales Numbers: I welcome critique of my math and numbersI think his math is based off a monthly client increase of 10%. So when mettrum and cgc both add 10% each per month. It's actually a 240% increase annually. That being said. I'll drop it down to 100%. If in november they sold 1200kg. Then next November they would have sold 2400kg + whatever for just CGC not including whatever MT brings to the table. I would guess there sales range next year is in the 3500 - 5500KG range once the MT merger is complete.
SquishyInc wrote: Just wanna say thanks to you and Yoda for putting some real thought and effort into your DD and sharing it with all of us. The only issue i saw with your numbers is in the projected sales per quarter, it just seems a bit on the high side as it projects approx 3000 kg sold when CGC reported around 1200 kg in November. That being said, i am no accountant. I'd also be interested to hear what people think a "reasonable" SP would be for the rev totals you listed.

 
ChacenAces wrote: Have I got this right? I am far from an expert. I look forward to polite challenges to my assumptions. Projections for CGC with MT sales per quarter minimum?

As of September 30, 2016. Source Links below.

  1. Health Canada average amount of marijuana for medical purposes per client shipment (grams/day) = 0.89
  2. Health Canada Total number of clients registered at end of quarter = 98,460
  3. Combined average consumer cost per gram of MT & Canopy = $8.34
  4. Combined number of MT & CGC patients = 37,700
  5. MT & CGC patient market share = 38%

* .89 grams per day X 90 days X 98,460 patients x .38 market share x $8.34 per gram = $24,994,358.50 projected sales per quarter.

-$99,977,4343 in annual medical sales for 2017 assuming no hiccups. Note this does not take into account that the rumour is patient registrations are now above 130,000 - this data not reported on HC website yet.

This sounds really good to me but I really like to look at things conservatively so please correct my logic or numbers herein as I look forward to intelligent conversation on this and by no means am I locked into this.

Also...assuming these numbers are correct...what would you put a share price at for Canopy doing:

1) $50,000,000 in sales per year?
2) $75,000,000 in sales per year?
3) $100,000,000 in sales per year?

Source Links:

  1. https://www.hc-sc.gc.ca/dhp-mps/marihuana/info/market-marche-eng.php
  2. https://news.lift.co/nov-1-2016-acmpr-market-summary/
  3. https://www.canopygrowth.com/
  4. https://www.mettrum.com/





Bullboard Posts